person

Nikolas V. B.

Country
Germany
Department
Hematology and Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
78
Sites with multiple studies

Has run more than one trial at 78 of 216 partner sites.

Specializations

Myeloproliferative Disorders

This investigator specializes in treating various forms of myeloproliferative neoplasms, with particular focus on myelofibrosis and its variants. Their research encompasses both primary and secondary forms of the disease.

  • Primary and Secondary Myelofibrosis
  • Polycythemia Vera
  • Essential Thrombocythemia

The investigator explores novel therapeutic combinations including JAK inhibitors and innovative treatment approaches.

Hematologic Malignancies

Their expertise extends to treating various blood cancers, with particular emphasis on chronic myeloid leukemia and primary CNS lymphoma. The research focuses on developing targeted therapies and optimizing treatment protocols.

  • Philadelphia Chromosome Positive CML
  • Primary CNS Lymphoma
  • Advanced Systemic Mastocytosis

The investigator evaluates novel therapeutic agents and their combinations in treating these conditions.

Targeted Therapies

The investigator works with various targeted therapeutic approaches, including tyrosine kinase inhibitors and novel molecular agents. Their research includes evaluation of treatments for BRAF-mutated malignancies.

  • Kinase Inhibitor Therapies
  • Molecular Targeted Treatments
  • Combination Therapy Approaches

Their work includes assessment of drug combinations and optimization of treatment protocols.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.